Trump's FDA boss resigning as admin taps next acting leader
Food and Drug Administration (FDA) Commissioner Marty Makary is resigning from his position Tuesday, a White House official told Fox News Digital. The official said that Makary's resignation has to...
By Fox News · Fox News
Food and Drug Administration (FDA) Commissioner Marty Makary is resigning from his position Tuesday, a White House official told Fox News Digital. The official said that Makary's resignation has to do with "process at the FDA" and not a specific issue, and said there is "no bad blood" between President Donald Trump and the outgoing commissioner. Health and Human Services Secretary Robert F. Kennedy Jr. pushed for Makary's resignation, according to the White House official. Kyle Diamantis, FDA deputy commissioner for Food, will serve as acting commissioner, Fox News Digital learned. TRUMP PICKS DR. MARTY MAKARY AS FOOD AND DRUG ADMINISTRATION COMMISSIONER Makary’s resignation followed mounting pressure from pro-life advocates and administration critics who had grown frustrated with his handling of several high-profile FDA decisions and claims he has slow-rolled MAHA initiatives, according to media reports in recent weeks. The Wall Street Journal reported on Friday that the president had reportedly already signed off on a plan to fire Makary, citing three familiar sources who cited Makary's handling of abortion and drug policy. "I've been reading about it, but I know nothing about it," Trump said the same day after he was asked by reporters if Makary would be fired. TRUMP CABINET SHAKEUP EXPANDS AFTER NOEM EXIT, BONDI FIRING — WHO’S UNDER PRESSURE NEXT? The resignation comes one day before Makary was set to testify in front of the Senate Appropriations Committee Wednesday. Though Makary's resignation is not attributable to a specific issue, according to the White House official, his tenure atop the FDA has put him at the center of fights over abortion drug mifepristone – otherwise known as the "abortion pill" – vaccine policy and drug approvals, frustrating pro-life activists and MAHA-aligned critics who argued the agency has moved too slowly to carry out Trump’s health agenda. When Trump was elected, pro-life groups and voters were banking on the administration roll…